These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2566170)

  • 21. Investigations into the mechanism by which sulfated polysaccharides inhibit HIV infection in vitro.
    McClure MO; Moore JP; Blanc DF; Scotting P; Cook GM; Keynes RJ; Weber JN; Davies D; Weiss RA
    AIDS Res Hum Retroviruses; 1992 Jan; 8(1):19-26. PubMed ID: 1346567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A fungal metabolite which inhibits the interaction of CD4 with major histocompatibility complex-encoded class II molecules.
    Gammon G; Chandler G; Depledge P; Elcock C; Wrigley S; Moore J; Cammarota G; Sinigaglia F; Moore M
    Eur J Immunol; 1994 Apr; 24(4):991-8. PubMed ID: 8149967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4+ lymphocyte function with early human immunodeficiency virus infection.
    Gurley RJ; Ikeuchi K; Byrn RA; Anderson K; Groopman JE
    Proc Natl Acad Sci U S A; 1989 Mar; 86(6):1993-7. PubMed ID: 2564677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and anti-HIV activities of low molecular weight aurintricarboxylic acid fragments and related compounds.
    Cushman M; Kanamathareddy S; De Clercq E; Schols D; Goldman ME; Bowen JA
    J Med Chem; 1991 Jan; 34(1):337-42. PubMed ID: 1704066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory influences of envelope glycoproteins of HIV-1 on normal immune responses.
    Chirmule N; Kalyanaraman V; Oyaizu N; Pahwa S
    J Acquir Immune Defic Syndr (1988); 1988; 1(5):425-30. PubMed ID: 2851650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sulfated polysaccharides as potent inhibitors of HIV-induced syncytium formation: a new strategy towards AIDS chemotherapy.
    Baba M; Schols D; Pauwels R; Nakashima H; De Clercq E
    J Acquir Immune Defic Syndr (1988); 1990; 3(5):493-9. PubMed ID: 1691288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection.
    Weinhold KJ; Lyerly HK; Stanley SD; Austin AA; Matthews TJ; Bolognesi DP
    J Immunol; 1989 May; 142(9):3091-7. PubMed ID: 2468713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins.
    Jansen RW; Molema G; Pauwels R; Schols D; De Clercq E; Meijer DK
    Mol Pharmacol; 1991 Jun; 39(6):818-23. PubMed ID: 2051994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A soluble CD4 protein selectively inhibits HIV replication and syncytium formation.
    Hussey RE; Richardson NE; Kowalski M; Brown NR; Chang HC; Siliciano RF; Dorfman T; Walker B; Sodroski J; Reinherz EL
    Nature; 1988 Jan; 331(6151):78-81. PubMed ID: 2829023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120.
    Dianzani U; Bragardo M; Buonfiglio D; Redoglia V; Funaro A; Portoles P; Rojo J; Malavasi F; Pileri A
    Eur J Immunol; 1995 May; 25(5):1306-11. PubMed ID: 7539755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A soluble recombinant polypeptide comprising the amino-terminal half of the extracellular region of the CD4 molecule contains an active binding site for human immunodeficiency virus.
    Berger EA; Fuerst TR; Moss B
    Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2357-61. PubMed ID: 2451247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flow cytometric method to monitor the destruction of CD4+ cells following their fusion with HIV-infected cells.
    Schols D; Pauwels R; Desmyter J; De Clercq E
    Cytometry; 1990; 11(6):736-43. PubMed ID: 1696539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [HIV envelope proteins are bound by human epidermal Langerhans cells by a binding site which differs from the site on the CD4 molecule, and are internalized by receptor endocytosis].
    Schmitt D; Dezutter-Dambuyant C; Hanau D; Schmitt DA; Kolbe HV; Kieny MP; Cazenave JP; Thivolet J
    C R Acad Sci III; 1989; 308(10):269-75. PubMed ID: 2543485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of in vitro inhibition of human immunodeficiency virus by purified recombinant CD4.
    Byrn RA; Sekigawa I; Chamow SM; Johnson JS; Gregory TJ; Capon DJ; Groopman JE
    J Virol; 1989 Oct; 63(10):4370-5. PubMed ID: 2550671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble CD4 molecules neutralize human immunodeficiency virus type 1.
    Traunecker A; Lüke W; Karjalainen K
    Nature; 1988 Jan; 331(6151):84-6. PubMed ID: 2829024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A rapid solution immunoassay to quantify binding of the human immunodeficiency virus envelope glycoprotein to soluble CD4.
    McQuade TJ; Pitts TW; Tarpley WG
    Biochem Biophys Res Commun; 1989 Aug; 163(1):172-6. PubMed ID: 2549987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding.
    Clayton LK; Sieh M; Pious DA; Reinherz EL
    Nature; 1989 Jun; 339(6225):548-51. PubMed ID: 2543930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deletion of T lymphocytes in human CD4 transgenic mice induced by HIV-gp120 and gp120-specific antibodies from AIDS patients.
    Wang ZQ; Orlikowsky T; Dudhane A; Mittler R; Blum M; Lacy E; Riethmüller G; Hoffmann MK
    Eur J Immunol; 1994 Jul; 24(7):1553-7. PubMed ID: 7913036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human eosinophils express CD4 protein and bind human immunodeficiency virus 1 gp120.
    Lucey DR; Dorsky DI; Nicholson-Weller A; Weller PF
    J Exp Med; 1989 Jan; 169(1):327-32. PubMed ID: 2783333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The D-mannose-specific lectin from Gerardia savaglia blocks binding of human immunodeficiency virus type I to H9 cells and human lymphocytes in vitro.
    Müller WE; Renneisen K; Kreuter MH; Schröder HC; Winkler I
    J Acquir Immune Defic Syndr (1988); 1988; 1(5):453-8. PubMed ID: 2906092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.